Antimicrobial Agents and Chemotherapy · 2016 · 32 citations · 16 references
Life SciencesMicrobiologyPharmacologyDiagnostic MicrobiologyMedical MicrobiologyMycologyAntifungal AgentsAntifungal ResistanceAntifungal TherapyAntifungal AntibioticsBroth MicrodilutionFungal AntibioticsFungal Drug ResistanceItraconazole TherapyMycelial Growth
ABSTRACT We determined the susceptibilities of 57 Talaromyces marneffei strains to anidulafungin, itraconazole, voriconazole, and posaconazole with MICs of 2 to 8, 0.002 to 0.004, 0.016 to 0.063, and 0.001 to 0.002 μg/ml by broth microdilution and >32, ≤0.002 to 0.008, ≤0.002 to 0.008, and ≤0.002 μg/ml by Etest, respectively, at yeast phase; MICs at mycelial phase for anidulafungin and posaconazole were 1 to 2 and 0.004 to 0.063 μg/ml, respectively. The results suggest promising activities of posaconazole. Etest can be used for testing of azoles against T. marneffei .
16
Disseminated Penicillium marneffei infection in Southeast Asia
Khuanchai Supparatpinyo, Chantana Khamwan, V Baosoung et al. · The Lancet · 1994 · 611 citations
Serodiagnosis of Penicillium marneffei infection
Kwok‐Yung Yuen, Samson S. Y. Wong, Pui Hing Chau et al. · The Lancet · 1994 · 103 citations